We are live on ! Find out more
SA

Sicart Associates Portfolio holdings

AUM $389M
1-Year Est. Return 42.46%
This Fund
S&P 500
This Quarter Est. Return
+1.92%
1 Year Est. Return
+42.46%
3 Year Est. Return
+89.06%
5 Year Est. Return
+118.65%
10 Year Est. Return
–
AUM
$191M
AUM Growth
+$23.3M
Cap. Flow
+$20.6M
Cap. Flow %
10.81%
Top 10 Hldgs %
51.45%
Holding
95
New
5
Increased
13
Reduced
26
Closed
7

Top Buys

Rank Stock Value
1
IONS icon
Ionis Pharmaceuticals
IONS
+$7.85M
2
MRK icon
Merck
MRK
+$4.29M
3
INTC icon
Intel
INTC
+$4.18M
4
CPB icon
Campbell Soup
CPB
+$4.18M
5
PG icon
Procter & Gamble
PG
+$3.88M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$727K
2
COF icon
Capital One
COF
+$575K
3
BA icon
Boeing
BA
+$516K
4
F icon
Ford
F
+$443K
5
NKTR icon
Nektar Therapeutics
NKTR
+$436K

Sector Composition

Rank Sector Weight
1 Healthcare 19.73%
2 Energy 15.98%
3 Technology 13.78%
4 Materials 8.52%
5 Consumer Staples 7.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BNY
51
Bank of New York Mellon
BNY
$106B
$809K 0.42%
15,000
– –
CL icon
52
Colgate-Palmolive
CL
$73.1B
$791K 0.41%
12,200
– –
SHV icon
53
iShares 0-1 Year Treasury Bond ETF
SHV
$20.8B
$764K 0.4%
6,920
+620
+10% +$68.4K
BHP icon
54
BHP
BHP
$215B
$600K 0.31%
13,452
– –
XOM icon
55
ExxonMobil
XOM
$644B
$596K 0.31%
7,200
– –
GE icon
56
GE Aerospace
GE
$374B
$588K 0.31%
8,931
– –
SLV icon
57
iShares Silver Trust
SLV
$28B
$577K 0.3%
38,080
-700
-2% -$10.9K
XBI icon
58
State Street SPDR S&P Biotech ETF
XBI
$9.95B
$557K 0.29%
5,855
-1,305
-18% -$120K
ALKS icon
59
Alkermes
ALKS
$8.22B
$515K 0.27%
12,500
– –
ADBE icon
60
Adobe
ADBE
$99.5B
$488K 0.26%
2,000
-200
-9% -$47.3K
VTI icon
61
Vanguard Morningstar Total Stock Market ETF
VTI
$660B
$488K 0.26%
3,475
– –
QCOM icon
62
Qualcomm
QCOM
$155B
$466K 0.24%
8,305
– –
ABT icon
63
Abbott
ABT
$183B
$451K 0.24%
7,389
– –
MA icon
64
Mastercard
MA
$502B
$442K 0.23%
2,250
– –
BAC icon
65
Bank of America
BAC
$435B
$428K 0.22%
15,200
– –
MTB icon
66
M&T Bank
MTB
$35.7B
$425K 0.22%
2,500
– –
BIIB icon
67
Biogen
BIIB
$30B
$406K 0.21%
1,400
– –
B
68
Barrick Mining
B
$61.5B
$404K 0.21%
30,785
-300
-1% -$3.93K
PSQ icon
69
ProShares Short QQQ
PSQ
$824M
$394K 0.21%
2,478
– –
SVC
70
Service Properties Trust
SVC
$1.04B
$352K 0.18%
2,460
-60
-2% -$8.1K
ITW icon
71
Illinois Tool Works
ITW
$82.6B
$348K 0.18%
2,500
– –
BND icon
72
Vanguard Total Bond Market
BND
$157B
$329K 0.17%
+4,141
New +$327K
TRIP icon
73
TripAdvisor
TRIP
$1.65B
$302K 0.16%
5,415
– –
IWF icon
74
iShares Russell 1000 Growth ETF
IWF
$121B
$288K 0.15%
+8,000
New +$282K
BGC icon
75
BGC Group
BGC
$5.45B
$286K 0.15%
39,264
-1,555
-4% -$12.4K
1 2
3
4

Similar funds

AIM
Aigen Investment Management New York $389M AUM 16.77% 1-Year Est. Return
WCM
Winthrop Capital Management Carmel, Indiana $389M AUM 16.76% 1-Year Est. Return
HP
Hilltop Partners Mishawaka, Indiana $390M AUM 16.72% 1-Year Est. Return
P8IP
Pier 88 Investment Partners San Francisco, California $390M AUM 10.13% 1-Year Est. Return
PFPGI
Patriot Financial Partners GP II Radnor, Pennsylvania $388M AUM
PG
Prostatis Group Hanover, Maryland $391M AUM 20.37% 1-Year Est. Return
S
SimplyRich Carlsbad, California $391M AUM 24.42% 1-Year Est. Return
LHC
Little House Capital Braintree, Massachusetts $387M AUM 27.85% 1-Year Est. Return

Sicart Associates's Q2 2018 Portfolio in Review

As of Q2 2018, Sicart Associates held 95 positions worth $191M, up 14% from $167M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Sicart Associates deployed $20.6M of net new capital in Q2 2018, opening 5 new positions and adding to 13 existing holdings. Its largest new stake was Invesco China Small Cap ETF: 36,660 shares worth $1.08M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 16% a quarter earlier, followed by Energy and Technology.

On the sell side, the largest reduction was Microsoft, an estimated $727K trimmed.

  • Sicart Associates's largest Q2 2018 buy was Invesco China Small Cap ETF: 36,660 shares worth $1.08M.
  • Sicart Associates added most to Ionis Pharmaceuticals in Q2 2018, an estimated $7.85M increase.
  • Sicart Associates's biggest Q2 2018 reduction was Microsoft, cutting an estimated $727K.
  • Sicart Associates fully exited Capital One in Q2 2018, selling an estimated $575K.
  • Sicart Associates's ten largest holdings make up 51% of its $191M portfolio in Q2 2018.
  • Sicart Associates opened 5 new positions and closed 7 in Q2 2018.
  • Sicart Associates's portfolio value rose 14% quarter-over-quarter to $191M.

Based on Sicart Associates's 13F filing for Q2 2018, filed 19 Jul 2018.